Evaluation the effect of vasopressin in ovarian endometriosis surgery

Phase 3

• Conditions: Female infertility associated with anovulation; N97.0; Treatment of ovarian endometrioma.

• Registration Number: IRCT20200925048836N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 9 November 2020

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 80

Inclusion Criteria

Age 18-45
With unilateral endometriosis of the ovaries undergoing cystectomy

Exclusion Criteria

Bilateral endometrioma
Menopausal women
Any contraindication for surgery

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Ovarian reserve. Timepoint: 0,3,6 Months post operation. Method of measurement: Blood sampling.

Secondary Outcome Measures

Name	Time	Method
The number of cauterization points needed for homeostasis. Timepoint: At time of operation. Method of measurement: The number of points that are catheterized by a bipolar Bissinger Medizintechnik device to perform homeostasis during a cystectomy is counted and recorded.;The amount of bleeding (milliliter) in both groups were recorded. Timepoint: At time of operation. Method of measurement: Amount of bleeding (milliliter) is measured according to suction device measuring.